Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (63933)	7/2/1999 10:58:00 PM
From: Skeeter Bug	Read Replies (1) \| Respond to of 132070

i agree. a one time write-off and asps at $7. with the bottom already in place. u gotta luv the idiots that believe this -s-. why? their mothers don't. -ng-

To: Knighty Tin who wrote (63933)	7/4/1999 12:25:00 PM
From: geewiz	Read Replies (1) \| Respond to of 132070

Mike, From someone who hasn't make the 3800% return on MU puts this cycle, are you rolling down and forward?? I still have hopes for the July 35's that I bought last april...... And what is the current opinion on the assemblers; JBL,SLR,SANM? Had I seen the decline in Enterprise software where I thought I saw a decline in fab investment, I'd be one very happy putter! The optimism on conversion to next generation chips is interesting; we have more processing capacity in the pentium than the public is willing to pay for, yet I read that Intel has started conversion of the Hillsborro plant to next generation. Gretchen's Sunday installment should not be missed! www10.nytimes.com For private use: On June 18, Iomega said it expected to report a shortfall in earnings for its second quarter and to post a loss of between 5 cents and 10 cents a share. Its revenues have dropped from earlier quarters, and Iomega attributed the decline to continued weakness in sales of its Jaz line and to a component shortage that led to lower-than-expected sales of Zip drives. The lone ray of sunshine in this gloomy picture comes from two Wall Street analysts who currently recommend buying Iomega. John Dean at Salomon Smith Barney, a subsidiary of Citigroup, rates the stock 1-S, the firm's most aggressive buy. payoff. Daniel Kunstler at J.P. Morgan Securities also likes the stock. Last April, Kunstler reduced his recommendation from outright "buy" to what he calls a long-term buy, presumably warning investors that a rebound at the company might take some time. No other big-name Wall Street firms are currently recommending Iomega shares. Normally, any break in the me-too analysis emanating from big brokerage firms is welcome. It isn't often, after all, that Wall Street offers a contrarian view on a company like the one Dean and Kunstler have taken on Iomega. But before they win plaudits for independent thought, one detail is worth noting. Last year, Iomega replaced its credit line of $60 million with a $150 million line that expires next year, secured by company inventories. The lead bankers on the financing are J.P. Morgan Securities and Citicorp Securities. Representatives of J.P. Morgan Securities and Citigroup say it is strictly a coincidence that they, Iomega's lead bankers, are also the only major firms currently recommending its stock. But if Iomega decides to raise money in the equity markets anytime soon, would anyone be surprised if one or both of these firms won the job of underwriting an Iomega offering? New York Times July 4,1999 later, art